Fig. 1From: Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanceEstimated Cumulative proportion of participants with virologic failure (confirmed HIV-1 RNA ≥ 1000 Copies/mL at or after 24 weeks) over time, in the overall study population and by selected characteristics of participants at study entryBack to article page